ALDEYRA THERAPEUTICS INC's ticker is and the CUSIP is 01438T906. A total of 3 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311 | -1.3% | 46,700 | +24.2% | 0.00% | – |
| Q2 2023 | $315 | +55.9% | 37,600 | +84.3% | 0.00% | – |
| Q1 2023 | $202 | -54.8% | 20,400 | -68.3% | 0.00% | – |
| Q4 2022 | $447 | -99.2% | 64,300 | +524.3% | 0.00% | – |
| Q3 2022 | $55,000 | -85.8% | 10,300 | -89.4% | 0.00% | – |
| Q2 2022 | $386,000 | -52.9% | 96,900 | -47.5% | 0.00% | -100.0% |
| Q1 2022 | $819,000 | -4.8% | 184,400 | -14.3% | 0.00% | 0.0% |
| Q4 2021 | $860,000 | +64.4% | 215,200 | +364.8% | 0.00% | – |
| Q3 2021 | $523,000 | -3.3% | 46,300 | -3.1% | 0.00% | -100.0% |
| Q2 2021 | $541,000 | +6662.5% | 47,800 | +682757.1% | 0.00% | – |
| Q1 2021 | $8,000 | -69.2% | 7 | -82.1% | 0.00% | – |
| Q4 2020 | $26,000 | +4.0% | 39 | +14.7% | 0.00% | – |
| Q3 2020 | $25,000 | +257.1% | 34 | +88.9% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 18 | +38.5% | 0.00% | – |
| Q4 2019 | $7,000 | -58.8% | 13 | -60.6% | 0.00% | – |
| Q3 2019 | $17,000 | -92.9% | 33 | -91.8% | 0.00% | -100.0% |
| Q2 2019 | $241,000 | -61.5% | 403 | -41.9% | 0.00% | -50.0% |
| Q1 2019 | $626,000 | +20766.7% | 694 | +17250.0% | 0.00% | – |
| Q4 2018 | $3,000 | -50.0% | 4 | -20.0% | 0.00% | – |
| Q3 2018 | $6,000 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 14,300 | $141,999 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 20,400 | $202 | 0.00% |